News Headlines

Display #
Title
Heartbeat Introduces New Agency Leadership
Tagrisso (osimertinib) receives US FDA full approval
Vertex CF combo succeeds in late-stage trials
U.S. senator launches opioid drugmaker probe
Neurological diseases cost the US nearly $800 billion per year
Vertex Consolidating R&D Ops in 3 Locations, Shutters Site in Canada
How to get adults to eat their vegetables? Study explores potential of spices and herbs use
Trump’s FDA Head Nominee to Recuse Himself From Decisions Involving 20+ Companies
EU rapid drug approval plan worries some national agencies
FDA approves Roche's OCREVUS™ (ocrelizumab) for relapsing and primary progressive forms of multiple sclerosis
U.S. approves Roche drug for severe form of MS
Brain implant lets paralyzed man feed himself using his thoughts
FDA approves Tesaro’s ovarian cancer drug
Mylan underpayment on EpiPen could exceed proposed settlement – study
Astrazeneca to share its robust early science in oncology with the medical community at AACR 2017
Elon Musk Launches Neuroscience Startup
Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb and the Cancer Research Institute announce collaboration to accelerate immuno-oncology research
Organogenesis Inc. Announces Acquisition of NuTech Medical
House Republicans consider reviving healthcare push: lawmaker
FDA approves first-in-human trial for neural-enabled prosthetic hand system developed at FIU
FDA approves eczema drug Dupixent
FDA approves new eczema drug Dupixent
Trump tastes failure as U.S. House healthcare bill collapses
Chinese drug approval for AstraZeneca’s Tagrisso
XELJANZ® (tofacitinib citrate) receives marketing authorisation in the European Union for the treatment of moderate to severe active rheumatoid arthritis
Scientists discover mechanism that causes cancer cells to self-destruct
Johnson & Johnson’s $100,000 Anti-Burnout Program for Top Execs
Nearly 500 Amgen Staffers to be Reassigned, Relocated or Laid Off in Restructuring
Gilead hepatitis C drug patent faces European challenge
New budget test puts UK on front line in global drug price fight